Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Alexander Pereboev"'
Autor:
Aintzane Zabaleta, Delia D'Avola, Itziar Echeverria, Diana Llopiz, Leyre Silva, Lorea Villanueva, José Ignacio Riezu-Boj, Esther Larrea, Alexander Pereboev, Juan José Lasarte, Iago Rodriguez-Lago, Mercedes Iñarrairaegui, Bruno Sangro, Jesús Prieto, Pablo Sarobe
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 2, Iss , Pp - (2015)
The lack of antiviral cellular immune responses in patients with chronic hepatitis C virus (HCV) infection suggests that T-cell vaccines may provide therapeutic benefit. Due to the central role that dendritic cells (DC) play in the activation of T-ce
Externí odkaz:
https://doaj.org/article/a824b1a51cd6450d8b80d26a263f2b52
Autor:
Tanja D. de Gruijl, Rik J. Scheper, David T. Curiel, Alexander Pereboev, Victor W. van Beusechem, Winald R. Gerritsen, Alfons J. van den Eertwegh, Thomas Tüting, Louis Boon, Jan de Groot, Dinja Oosterhoff, Basav N. Hangalapura
PDF file - 1813K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::872df2f6abaf666a9ad0a952b8df41bc
https://doi.org/10.1158/0008-5472.22388964.v1
https://doi.org/10.1158/0008-5472.22388964.v1
Autor:
Tanja D. de Gruijl, Rik J. Scheper, David T. Curiel, Alexander Pereboev, Victor W. van Beusechem, Winald R. Gerritsen, Alfons J. van den Eertwegh, Thomas Tüting, Louis Boon, Jan de Groot, Dinja Oosterhoff, Basav N. Hangalapura
PDF file - 1003K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05d643f1bd707977f864e6bdbf7b9c65
https://doi.org/10.1158/0008-5472.22388961.v1
https://doi.org/10.1158/0008-5472.22388961.v1
Autor:
Tanja D. de Gruijl, Rik J. Scheper, David T. Curiel, Alexander Pereboev, Victor W. van Beusechem, Winald R. Gerritsen, Alfons J. van den Eertwegh, Thomas Tüting, Louis Boon, Jan de Groot, Dinja Oosterhoff, Basav N. Hangalapura
PDF file - 78K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62024daf50b0aebffa99c1c546de7b47
https://doi.org/10.1158/0008-5472.22388958.v1
https://doi.org/10.1158/0008-5472.22388958.v1
Autor:
Juan José Lasarte, Pablo Sarobe, Leyre Silva, Itziar Echeverria, Francisco Borrás-Cuesta, Maria Cubero, Jose I Riezu-Boj, Jesús Prieto, Marta Bes, Juan Ignacio Esteban, Alexander Pereboev, Aintzane Zabaleta
Publikováno v:
Hepatology. 54:28-37
Injection of dendritic cells (DCs) presenting viral proteins constitutes a promising approach to stimulate T cell immunity against hepatitis C virus (HCV). Here we describe a strategy to enhance antigen loading and immunostimulatory functions of DCs
Publikováno v:
American Journal of Physiology-Endocrinology and Metabolism. 298:E1295-E1304
Recombinant adenovirus (Ad) vectors can initiate an inflammatory response, limiting its use in gene therapy and basic research. Despite increased efforts to better understand Ad infection, little is known about how it affects cellular metabolic respo
Autor:
Hideyo Ugai, Natalya Belousova, Paul Dent, Miho Murakami, David T. Curiel, Alexander Pereboev, Paul B. Fisher, Maaike Everts
Publikováno v:
The Prostate. 70:362-376
BACKGROUND—We have developed a range of adenoviral (Ad) vectors based on human adenovirus serotype 5 (HAdV-5) displaying the fiber shaft and knob domains of species B viruses (HAdV-3, HAdV-11, or HAdV-35). These species B Ads utilize different cell
Autor:
Viktor Svyatchenko, Viktoriya Borisevich, Valery B. Loktev, Mikhail A. Shakhmatov, Vladimir Yamshchikov, Deborah A Hudman, George Tsuladze, Kazachinskaia Ei, Ivan A. Razumov, Alexander Pereboev
Publikováno v:
Antiviral Research
Gene-based delivery of recombinant antibody genes is a promising therapeutic strategy offering numerous advantages including sustained antibody levels, better safety profile and lower production cost. Here we describe generation of a recombinant anti
Autor:
Norihiro Nishimoto, Naoko Yoshio-Hoshino, David T. Curiel, Alexander Pereboev, Yasuo Adachi, Chieko Aoki
Publikováno v:
Cancer Research. 67:871-875
Interleukin-6 (IL-6) is a key molecule involved in the pathogenesis of several inflammatory diseases and malignancies. Treatments that inhibit IL-6 mitigate the clinical conditions of such diseases. Here, we report on the development of a new recepto
Autor:
Iago Rodríguez-Lago, Bruno Sangro, Diana Llopiz, Esther Larrea, Delia D'Avola, Jesús Prieto, Mercedes Iñarrairaegui, Alexander Pereboev, Pablo Sarobe, Itziar Echeverria, Aintzane Zabaleta, Lorea Villanueva, Jose I Riezu-Boj, Juan José Lasarte, Leyre Silva
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 2, Iss, Pp-(2015)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
The lack of antiviral cellular immune responses in patients with chronic hepatitis C virus (HCV) infection suggests that T-cell vaccines may provide therapeutic benefit. Due to the central role that dendritic cells (DC) play in the activation of T-ce